Annual Short Term Debt
$5.22 M
-$1.77 M-25.30%
31 December 2023
Summary:
C4 Therapeutics annual short term debt is currently $5.22 million, with the most recent change of -$1.77 million (-25.30%) on 31 December 2023. During the last 3 years, it has risen by +$4.18 million (+400.86%). CCCC annual short term debt is now -25.30% below its all-time high of $6.99 million, reached on 31 December 2022.CCCC Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Short Term Debt
$5.63 M
+$139.00 K+2.53%
30 September 2024
Summary:
C4 Therapeutics quarterly short term debt is currently $5.63 million, with the most recent change of +$139.00 thousand (+2.53%) on 30 September 2024. Over the past year, it has increased by +$545.00 thousand (+10.71%). CCCC quarterly short term debt is now -63.17% below its all-time high of $15.29 million, reached on 30 June 2023.CCCC Quarterly Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CCCC Short Term Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -25.3% | +10.7% |
| 3 y3 years | +400.9% | +378.5% |
| 5 y5 years | +611.0% | - |
CCCC Short Term Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -25.3% | +400.9% | -63.2% | +378.5% |
| 5 y | 5 years | -25.3% | +611.0% | -63.2% | +540.0% |
| alltime | all time | -25.3% | +611.0% | -63.2% | +540.0% |
C4 Therapeutics Short Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $5.63 M(+2.5%) |
| June 2024 | - | $5.49 M(+2.6%) |
| Mar 2024 | - | $5.36 M(+2.6%) |
| Dec 2023 | $5.22 M(-25.3%) | $5.22 M(+2.6%) |
| Sept 2023 | - | $5.09 M(-66.7%) |
| June 2023 | - | $15.29 M(+114.9%) |
| Mar 2023 | - | $7.11 M(+1.8%) |
| Dec 2022 | $6.99 M | $6.99 M(+2.3%) |
| Sept 2022 | - | $6.83 M(+165.2%) |
| June 2022 | - | $2.57 M(+3.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $2.48 M(+85.7%) |
| Dec 2021 | $1.33 M(+28.0%) | $1.33 M(+13.3%) |
| Sept 2021 | - | $1.18 M(+4.1%) |
| June 2021 | - | $1.13 M(+4.1%) |
| Mar 2021 | - | $1.09 M(+4.2%) |
| Dec 2020 | $1.04 M(+18.4%) | $1.04 M(+4.2%) |
| Sept 2020 | - | $1.00 M(+4.3%) |
| June 2020 | - | $959.00 K(+9.0%) |
| Dec 2019 | $880.00 K(+19.9%) | $880.00 K |
| Dec 2018 | $734.00 K | - |
FAQ
- What is C4 Therapeutics annual short term debt?
- What is the all time high annual short term debt for C4 Therapeutics?
- What is C4 Therapeutics annual short term debt year-on-year change?
- What is C4 Therapeutics quarterly short term debt?
- What is the all time high quarterly short term debt for C4 Therapeutics?
- What is C4 Therapeutics quarterly short term debt year-on-year change?
What is C4 Therapeutics annual short term debt?
The current annual short term debt of CCCC is $5.22 M
What is the all time high annual short term debt for C4 Therapeutics?
C4 Therapeutics all-time high annual short term debt is $6.99 M
What is C4 Therapeutics annual short term debt year-on-year change?
Over the past year, CCCC annual short term debt has changed by -$1.77 M (-25.30%)
What is C4 Therapeutics quarterly short term debt?
The current quarterly short term debt of CCCC is $5.63 M
What is the all time high quarterly short term debt for C4 Therapeutics?
C4 Therapeutics all-time high quarterly short term debt is $15.29 M
What is C4 Therapeutics quarterly short term debt year-on-year change?
Over the past year, CCCC quarterly short term debt has changed by +$545.00 K (+10.71%)